SEMPERIT AG HLD Goodwill and Intangible Assets 2019-2025 | SEIGY
SEMPERIT AG HLD goodwill and intangible assets from 2019 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
| SEMPERIT AG HLD Annual Goodwill and Intangible Assets (Millions of US $) |
|
|---|---|
| 2024 | $131 |
| 2023 | $135 |
| 2022 | $7 |
| 2021 | $10 |
| 2020 | $9 |
| 2019 | $9 |
| 2018 | $14 |
| SEMPERIT AG HLD Quarterly Goodwill and Intangible Assets (Millions of US $) |
|
|---|---|
| 2025-03-31 | $126 |
| 2024-12-31 | $131 |
| 2024-09-30 | $133 |
| 2024-06-30 | $130 |
| 2024-03-31 | $132 |
| 2023-12-31 | $135 |
| 2023-09-30 | $120 |
| 2023-06-30 | $6 |
| 2023-03-31 | $6 |
| 2022-12-31 | $7 |
| 2022-09-30 | $7 |
| 2022-06-30 | $8 |
| 2022-03-31 | $9 |
| 2021-12-31 | $10 |
| 2021-09-30 | $9 |
| 2021-06-30 | $9 |
| 2021-03-31 | $10 |
| 2020-12-31 | $9 |
| 2020-09-30 | $9 |
| 2020-06-30 | $8 |
| 2020-03-31 | $11 |
| 2019-12-31 | $9 |
| 2019-09-30 | $9 |
| 2019-06-30 | $10 |
| 2019-03-31 | $12 |
| 2018-12-31 | $14 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.317B | $0.732B |
| Semperit Aktiengesellschaft Holding develops, produces and sells rubber and plastic products for the medical and industrial sectors. Its operating segment consists of Sempermed, Semperflex, Sempertrans and Semperform. Sempermed segment manufactures examination and surgical gloves in the medical area, as well as protective gloves; Semperflex segment develops, produces and sells hydraulic and industrial hoses; Sempertrans segment manufactures textile and steel-cord conveyor belts for use in mining, steel, cement, civil engineering and transport industries, as well as in power stations; Semperform segment manufactures elastomer and insulation profiles for windows, doors, and facades; escalator handrails; vibration-reducing foils for skis and snowboards and custom molded parts and rubber rings for ropeways. Semperit Aktiengesellschaft Holding is based in Vienna, Austria. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.027B | 26.85 |
| Boston Scientific (BSX) | United States | $157.644B | 37.59 |
| Stryker (SYK) | United States | $150.755B | 30.69 |
| EssilorLuxottica (ESLOY) | France | $144.001B | 0.00 |
| Medtronic (MDT) | Ireland | $118.256B | 16.67 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.628B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.188B | 24.69 |
| ResMed (RMD) | United States | $41.753B | 29.86 |
| GE HealthCare Technologies (GEHC) | United States | $33.827B | 15.90 |
| Agilent Technologies (A) | United States | $33.605B | 21.91 |
| Koninklijke Philips (PHG) | Netherlands | $26.779B | 17.71 |
| Terumo (TRUMY) | Japan | $26.532B | 31.44 |
| Insulet (PODD) | United States | $23.358B | 78.26 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.303B | 13.56 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.337B | 0.00 |
| Baxter (BAX) | United States | $12.584B | 9.72 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.027B | 29.48 |
| Lantheus Holdings (LNTH) | United States | $3.785B | 10.23 |
| Envista Holdings (NVST) | United States | $3.513B | 24.58 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.268B | 14.50 |
| Perrigo (PRGO) | Ireland | $3.265B | 8.15 |
| ICU Medical (ICUI) | United States | $3.109B | 21.17 |
| Haemonetics (HAE) | United States | $2.661B | 11.88 |
| LeMaitre Vascular (LMAT) | United States | $2.157B | 46.25 |
| Acuren (TIC) | United States | $2.156B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $2.117B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.896B | 11.93 |
| Green Thumb Industries (GTBIF) | United States | $1.888B | 81.09 |
| AtriCure (ATRC) | United States | $1.882B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.596B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.323B | 16.91 |
| AdaptHealth (AHCO) | United States | $1.246B | 17.71 |
| BioLife Solutions (BLFS) | United States | $1.229B | 2565.00 |
| Neogen (NEOG) | United States | $1.223B | 19.41 |
| Kestra Medical Technologies (KMTS) | United States | $0.952B | 0.00 |
| InMode (INMD) | Israel | $0.941B | 8.70 |
| Valneva SE (VALN) | France | $0.762B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.683B | 0.00 |
| SNDL (SNDL) | Canada | $0.649B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.618B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.615B | 0.00 |
| ZimVie (ZIMV) | United States | $0.535B | 20.62 |
| Surmodics (SRDX) | United States | $0.496B | 0.00 |
| Evolus (EOLS) | United States | $0.495B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.468B | 16.11 |
| CeriBell (CBLL) | United States | $0.420B | 0.00 |
| Owens & Minor (OMI) | United States | $0.387B | 3.43 |
| Sanuwave Health (SNWV) | United States | $0.360B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.353B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.352B | 0.00 |
| Brainsway (BWAY) | Israel | $0.301B | 61.15 |
| Sanara MedTech (SMTI) | United States | $0.300B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.299B | 0.00 |
| Omeros (OMER) | United States | $0.298B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.296B | 0.00 |
| High Tide (HITI) | Canada | $0.283B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.273B | 20.74 |
| Cerus (CERS) | United States | $0.255B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.255B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.254B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.241B | 0.00 |
| Organigram Global (OGI) | Canada | $0.221B | 0.00 |
| Quanterix (QTRX) | United States | $0.218B | 0.00 |
| Exagen (XGN) | United States | $0.218B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.195B | 16.24 |
| FitLife Brands (FTLF) | United States | $0.173B | 21.31 |
| Biote (BTMD) | United States | $0.164B | 5.43 |
| Jushi Holdings (JUSHF) | United States | $0.151B | 0.00 |
| Jin Medical (ZJYL) | China | $0.130B | 0.00 |
| MacroGenics (MGNX) | United States | $0.114B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.114B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 12.32 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Apyx Medical (APYX) | United States | $0.079B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.065B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.058B | 0.00 |
| ImmuCell (ICCC) | United States | $0.057B | 32.90 |
| Veru (VERU) | United States | $0.051B | 0.00 |
| Zynex (ZYXI) | United States | $0.050B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 33.67 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 14.62 |
| Trinity Biotech (TRIB) | Ireland | $0.027B | 0.00 |
| Senestech (SNES) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.016B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Sharps Technology (STSS) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |